Yan Su Selected Research

Antineoplastic Agents (Antineoplastics)

4/2024	Mitochondria-targeted ruthenium complexes can be generated in vitro and in living cells to target triple-negative breast cancer cells by autophagy inhibition.
4/2024	Dual inhibition of oxidative phosphorylation and glycolysis to enhance cancer therapy.
11/2023	Cyclometalated iridium(III) complexes as anti-breast cancer and anti-metastasis agents via STAT3 inhibition.
1/2022	Mitochondria-targeted Pt(IV) prodrugs conjugated with an aggregation-induced emission luminogen against breast cancer cells by dual modulation of apoptosis and autophagy inhibition.
1/2022	Performance of Ir(III)-Based Anticancer Agents in the Treatment of Cisplatin-Resistant Cancer Cells.
9/2021	7S,15R-Dihydroxy-16S,17S-Epoxy-Docosapentaenoic Acid, a Novel DHA Epoxy Derivative, Inhibits Colorectal Cancer Stemness through Repolarization of Tumor-Associated Macrophage Functions and the ROS/STAT3 Signaling Pathway.
1/2020	Unveiling the anti-cancer mechanism for half-sandwich and cyclometalated Ir(iii)-based complexes with functionalized α-lipoic acid.
12/2013	[Report of a case with secondary acute promyelocytic leukemia after therapy for hemophagocytic lymphohistiocytosis and review of literature].
8/2005	Increased plasma MMP9 in integrin alpha1-null mice enhances lung metastasis of colon carcinoma cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yan Su Research Topics

Disease

65	Neoplasms (Cancer) 12/2024 - 01/2005
17	Neuroblastoma 05/2024 - 07/2018
13	Neoplasm Metastasis (Metastasis) 04/2024 - 01/2005
12	Infections 11/2023 - 12/2003
10	Inflammation (Inflammations) 01/2024 - 03/2009
9	Autoimmune Diseases (Autoimmune Disease) 06/2020 - 10/2007
8	Lung Neoplasms (Lung Cancer) 04/2024 - 01/2005
7	Fibrosis (Cirrhosis) 03/2024 - 05/2007
6	Hypersensitivity (Allergy) 04/2024 - 01/2013
5	Hypoxia (Hypoxemia) 02/2024 - 01/2006
5	Hemophilia A (Haemophilia) 02/2015 - 10/2007
4	Pain (Aches) 05/2024 - 01/2014
4	Breast Neoplasms (Breast Cancer) 04/2024 - 01/2022
4	Wounds and Injuries (Trauma) 01/2023 - 09/2014
4	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 05/2021 - 04/2014
4	Carcinoma (Carcinomatosis) 01/2015 - 08/2005
3	Uterine Cervical Neoplasms (Cancer of the Cervix) 12/2024 - 01/2016
3	Type 2 Diabetes Mellitus (MODY) 03/2024 - 03/2008
3	Obesity 03/2024 - 02/2022
3	Starvation 11/2023 - 01/2022
3	Compression Fractures (Compression Fracture) 05/2023 - 01/2017
3	Carcinogenesis 03/2023 - 10/2020
3	Glioma (Gliomas) 02/2023 - 12/2021
3	Sepsis (Septicemia) 01/2023 - 01/2021
3	Hepatocellular Carcinoma (Hepatoma) 12/2022 - 09/2014
3	Osteoporosis 12/2022 - 01/2011
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022 - 01/2014
3	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2022 - 11/2020
3	Virus Diseases (Viral Diseases) 10/2021 - 07/2012
3	Hemorrhage 01/2021 - 05/2013
3	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 09/2020 - 12/2013
3	Hyperlipidemias (Hyperlipidemia) 02/2014 - 01/2013
3	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2013 - 09/2010
3	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 09/2011 - 09/2010
3	Influenza in Birds (Avian Flu) 03/2009 - 01/2008
2	Brain Ischemia (Cerebral Ischemia) 04/2024 - 01/2017
2	Polycystic Ovary Syndrome (Syndrome, Stein-Leventhal) 03/2024 - 09/2023
2	Mitochondrial Diseases (Mitochondrial Disease) 03/2024 - 02/2022
2	Weight Loss (Weight Reduction) 03/2024 - 12/2022
2	Fatigue 01/2024 - 01/2022
2	Diabetes Mellitus 01/2024 - 01/2021
2	Rheumatoid Arthritis 01/2024 - 06/2012
2	Insulin Resistance 11/2023 - 05/2017

Drug/Important Bio-Agent (IBA)

27	Proteins (Proteins, Gene)FDA Link 01/2024 - 12/2003
15	Biomarkers (Surrogate Marker)IBA 03/2024 - 12/2011
12	DNA (Deoxyribonucleic Acid)IBA 04/2024 - 10/2009
9	Antineoplastic Agents (Antineoplastics)IBA 04/2024 - 08/2005
8	AntigensIBA 03/2022 - 09/2010
7	CollagenIBA 01/2024 - 05/2007
6	Peptides (Polypeptides)IBA 03/2024 - 07/2008
6	Glucose (Dextrose)FDA LinkGeneric 03/2024 - 01/2015
6	Reactive Oxygen Species (Oxygen Radicals)IBA 02/2024 - 05/2015
6	Messenger RNA (mRNA)IBA 11/2023 - 01/2006
5	Matrix Metalloproteinases (MMPs)IBA 03/2024 - 01/2005
5	RNA (Ribonucleic Acid)IBA 03/2024 - 12/2003
5	Cisplatin (Platino)FDA LinkGeneric 03/2024 - 01/2020
5	LigandsIBA 01/2024 - 01/2014
5	LipidsIBA 01/2024 - 01/2013
5	Hemoglobins (Hemoglobin)IBA 07/2023 - 09/2009
5	Therapeutic UsesIBA 01/2023 - 01/2021
5	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2023 - 01/2016
5	VaccinesIBA 10/2020 - 01/2016
5	IntegrinsIBA 06/2012 - 01/2005
4	Inosine Triphosphate (ITP)IBA 05/2021 - 04/2014
4	EpitopesIBA 01/2013 - 07/2008
3	IridiumIBA 04/2024 - 11/2023
3	Transcription Factors (Transcription Factor)IBA 04/2024 - 01/2018
3	GraphiteIBA 04/2024 - 01/2020
3	ProdrugsIBA 02/2024 - 01/2022
3	CatalaseIBA 02/2024 - 10/2020
3	Docosahexaenoic AcidsIBA 01/2024 - 02/2022
3	MetalsIBA 11/2023 - 12/2021
3	Adenosine Triphosphate (ATP)IBA 11/2023 - 01/2022
3	diHEP-DPAIBA 01/2023 - 09/2021
3	Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric 01/2023 - 10/2020
3	Phosphopyruvate Hydratase (Enolase)IBA 01/2023 - 03/2020
3	Anti-Bacterial Agents (Antibiotics)IBA 01/2023 - 08/2019
3	MicroRNAs (MicroRNA)IBA 01/2021 - 01/2019
3	CytokinesIBA 10/2020 - 07/2006
3	Cell-Free Nucleic AcidsIBA 02/2020 - 07/2018
3	DNA VaccinesIBA 12/2017 - 01/2016
3	Immunoglobulin G (IgG)IBA 01/2013 - 07/2008
3	Hemagglutinins (Hemagglutinin)IBA 03/2009 - 01/2008
2	Interleukin-10 (Interleukin 10)IBA 12/2024 - 01/2011
2	Chimeric Antigen ReceptorsIBA 04/2024 - 04/2021
2	Indicators and Reagents (Reagents)IBA 04/2024 - 01/2021
2	PlatinumIBA 04/2024 - 01/2022
2	MelatoninIBA 04/2024 - 11/2006
2	A-Form DNA (A-DNA)IBA 02/2024 - 12/2017
2	Glutathione (Reduced Glutathione)IBA 02/2024 - 11/2023
2	Ribose (D-Ribose)IBA 01/2024 - 01/2023
2	Lipoxygenase (Lipoxygenase-1)IBA 01/2024 - 02/2022

Therapy/Procedure

42	Therapeutics 05/2024 - 04/2007
22	Drug Therapy (Chemotherapy) 05/2024 - 09/2008
9	Immunotherapy 05/2024 - 05/2013
3	Hematopoietic Stem Cell Transplantation 11/2020 - 01/2018
3	Transplantation 02/2015 - 10/2007
2	Combination Drug Therapy (Combination Chemotherapy) 04/2024 - 01/2024
2	Quantum Dots (Quantum Dot) 04/2024 - 11/2023
2	Mediterranean Diet 11/2023 - 01/2022